GlassScriptPhysician profile
Brandon James Ferney
NPI 1992786115
$4,510.03
in general payments reported to CMS, 2019-2025
12 companies · $457 in 2025
The $457 reported for 2025 was less than what a typical Adult Reconstructive Orthopaedic Surgery provider received nationally (typical 2025 total: $1,425).
See the full distribution for Adult Reconstructive Orthopaedic Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $385 · 2020: $27.96 · 2021: $2,209 · 2022: $57.66 · 2023: $1,183 · 2024: $191 · 2025: $457.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $895 · Travel and Lodging: $782 · Education: $154.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $894.98 |
| Travel and Lodging | $781.60 |
| Education | $154.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $2,050.20 | 2019-2022 | |
| Depuy Synthes Sales INC. | $1,492.91 | 2019-2025 | |
| Medical Device Business Services, INC. | $524.29 | 2023-2025 | Attune |
| Zimmer Biomet Holdings, INC. | $154.04 | 2024 | Persona |
| Smith+Nephew, INC. | $88.38 | 2021 | |
| Pfizer INC. | $68.37 | 2020-2024 | |
| Pacira Therapeutics, INC. | $47.29 | 2020-2021 | |
| Boston Scientific Corporation | $22.46 | 2023 | |
| Bioventus LLC | $19.31 | 2024 | Durolane |
| Avanos Medical | $17.58 | 2021 | |
| Molnlycke Health Care US, LLC | $12.69 | 2019 | |
| Kci USA, INC. | $12.51 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brandon Ferney listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.